drugset / Trial / NCT04632927
Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare the safety and efficacy of secukinumab and ustekinumab in patients with active psoriatic arthritis who showed failure to previous TNFα-inhibitor treatment
Timeline
- Start
- 2020-12-21
- Primary completion
- 2024-10-22
- Completion
- 2024-10-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Secukinumab | Monoclonal antibody | — | Subcutaneous |
| Subject | Ustekinumab | Monoclonal antibody | — | — |